Eisai
4523.T
#2013
Rank
HK$62.30 B
Marketcap
HK$221.02
Share price
3.80%
Change (1 day)
-40.25%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): HK$17.10

According to Eisai's latest financial reports the company's current EPS (TTM) is HK$17.00. In 2022 the company made an earnings per share (EPS) of HK$12.48 a decrease over its 2021 EPS that were of HK$55.40.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$17.1037.01%
2022HK$12.48-77.48%
2021HK$55.40-41.88%
2020HK$95.31-0.94%
2019HK$96.2252.59%
2018HK$63.06124.17%
2017HK$28.13-49.42%
2016HK$55.6237.08%
2015HK$40.58-11.75%
2014HK$45.98-3.23%
2013HK$47.51-18.56%
2012HK$58.34-15.51%
2011HK$69.05-3.75%
2010HK$71.75-1.36%
2009HK$72.73